Effectiveness of meningococcal serogroup C vaccine programmes

Hudson et al.

Anderson, E. N. (1977) · Journal of California Anthropology, The · Cited by 2,550 · see citing works

"Herd Immunity": A Rough Guide

Fine, P. E., Eames, K. T. D., & Heymann, D. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir007 · Cited by 1,256 · see citing works

Meningococcal Disease

Rosenstein, N. E., Perkins, B. A., Stephens, D. S., Popović, T., & Hughes, J. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441807 · Cited by 1,177 · see citing works

Epidemic meningitis, meningococcaemia, and Neisseria meningitidis

Stephens, D. S., Greenwood, B., & Brandtzaeg, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61016-2 · Cited by 978 · see citing works

Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management

van Deuren, M., Brandtzaeg, P., & van der Meer, J. W. M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.144-166.2000 · Cited by 585 · see citing works

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

Trotter, C. L., Andrews, N. J., Kaczmarski, E. B., Miller, E., & Ramsay, M. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16725-1 · Cited by 571 · see citing works

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

Miller, E. J., SALISBURY, D. M., & Ramsay, M. E. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00299-7 · Cited by 483 · see citing works

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

Rosenstein, N. E., Perkins, B. A., Stephens, D. S., Lefkowitz, L. B., Cartter, M. L., Danila, R., Cieslak, P. R., Shutt, K. A., Popović, T., Schuchat, A., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315158 · Cited by 449 · see citing works

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

Maiden, M. C. J., Ibarz-Pavón, A. B., Urwin, R., Gray, S. J., Andrews, N. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527401 · Cited by 442 · see citing works

Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group

Maslanka, S., Gheesling, L. L., Libutti, D. E., Donaldson, K. B. J., Harakeh, H. S., Dykes, J. K., Arhin, F. F., Devi, S. J., Frasch, C. E., Huang, J., et al. (1997) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.4.2.156-167.1997 · Cited by 427 · see citing works

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination

Maiden, M. C., & Stuart, J. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08679-8 · Cited by 418 · see citing works

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

Ramsay, M. E., Andrews, N. J., Trotter, C. L., Kaczmarski, E. B., & Miller, E. (2003) · BMJ · doi:10.1136/bmj.326.7385.365 · Cited by 409 · see citing works

Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in England

Andrews, N. J., Borrow, R., & Miller, E. J. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.5.780-786.2003 · Cited by 323 · see citing works

Induction of Immunologic Memory by Conjugated vs Plain Meningococcal C Polysaccharide Vaccine in Toddlers

MacDonald, N. E., Halperin, S. A., Law, B. J., Forrest, B. D., Danzig, L. E., & Granoff, D. M. (1998) · JAMA · doi:10.1001/jama.280.19.1685 · Cited by 248 · see citing works

Ability of 3 Different Meningococcal C Conjugate Vaccines to Induce Immunologic Memory after a Single Dose in UK Toddlers

Richmond, P., Borrow, R., Goldblatt, D., Findlow, J., Martin, S. L., Morris, R., Cartwright, K. A. V., & Miller, E. (2001) · The Journal of Infectious Diseases · doi:10.1086/317646 · Cited by 218 · see citing works

Immunogenicity of a Tetravalent Meningococcal Glycoconjugate Vaccine in Infants

Snape, M. D., Perrett, K. P., Ford, K. J., John, T. M., Pace, D., Yu, L., Langley, J. M., McNeil, S., Dull, P. M., Ceddia, F., et al. (2008) · JAMA · doi:10.1001/jama.2007.29-c · Cited by 215 · see citing works

Standardization and a Multilaboratory Comparison ofNeisseria meningitidisSerogroup A and C Serum Bactericidal Assays

Maslanka, S. E., Gheesling, L. L., Libutti, D. E., et al. (1997) · Cited by 214 · see citing works

Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity

Campbell, H. J., Andrews, N. J., Borrow, R., Trotter, C. L., & Miller, E. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00529-09 · Cited by 213 · see citing works

Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group

Schlesinger, Y. (1992) · JAMA · doi:10.1001/jama.267.11.1489 · Cited by 208 · see citing works

Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs

Trotter, C. L., & Maiden, M. C. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.48 · Cited by 203 · see citing works

Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease

Frasch, C. E., Borrow, R., & Donnelly, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.065 · Cited by 190 · see citing works

Dynamic Models of Meningococcal Carriage, Disease, and the Impact of Serogroup C Conjugate Vaccination

Trotter, C. L., Gay, N. J., & Edmunds, W. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi160 · Cited by 176 · see citing works

Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain

Larrauri, A., Cano, R., García, M. J. S., & de Mateo, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.03.045 · Cited by 171 · see citing works

Clinical and Immunologic Risk Factors for Meningococcal C Conjugate Vaccine Failure in the United Kingdom

Auckland, C., Gray, S., Borrow, R., Andrews, N. J., Goldblatt, D., Ramsay, M. E., & Miller, E. (2006) · The Journal of Infectious Diseases · doi:10.1086/509619 · Cited by 143 · see citing works

Conjugate vaccines

Goldblatt, D. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01109.x · Cited by 142 · see citing works

PROTECTION FROM ROUTINE VACCINATION AT THE AGE OF 14 MONTHS WITH MENINGOCOCCAL SEROGROUP C CONJUGATE VACCINE IN THE NETHERLANDS

de Greeff, S. C., de Melker, H. E., Spanjaard, L., Schouls, L. M., & ENDE, A. V. D. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000195594.41449.c6 · Cited by 130 · see citing works

Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine

Borrow, R., Andrews, N. J., Findlow, H., Waight, P., Southern, J., Crowley-Luke, A., Stapley, L., England, A., Findlow, J., & Miller, E. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00384-09 · Cited by 115 · see citing works

Antibody Persistence and Immunological Memory at Age 4 Years after Meningococcal Group C Conjugate Vaccination in Children in the United Kingdom

Borrow, R., Goldblatt, D., Andrews, N. J., Southern, J., Ashton, L., Deane, S., Morris, R., Cartwright, K. A. V., & Miller, E. (2002) · The Journal of Infectious Diseases · doi:10.1086/344324 · Cited by 114 · see citing works

CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells

Kelly, D. F., Snape, M. D., Clutterbuck, E., Green, S., Snowden, C., Diggle, L., Yu, L., Borkowski, A., Moxon, E. R., & Pollard, A. J. (2006) · Blood · doi:10.1182/blood-2006-01-009282 · Cited by 107 · see citing works

Immunogenicity of, and Immunologic Memory to, a Reduced Primary Schedule of Meningococcal C-Tetanus Toxoid Conjugate Vaccine in Infants in the United Kingdom

Borrow, R., Goldblatt, D., Finn, A. H. R., Southern, J., Ashton, L., Andrews, N. J., Lal, G., Riley, C., Rahim, R., Cartwright, K. A. V., et al. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.5549-5555.2003 · Cited by 103 · see citing works

Effectiveness of a Mass Immunization Campaign Using Serogroup C Meningococcal Conjugate Vaccine

Wals, P. D. (2004) · JAMA · doi:10.1001/jama.292.20.2491 · Cited by 101 · see citing works

Lack of Serum Bactericidal Activity in Preschool Children Two Years After a Single Dose of Serogroup C Meningococcal Polysaccharide-Protein Conjugate Vaccine

Snape, M. D., Kelly, D. F., Green, B., Moxon, E. R., Borrow, R., & Pollard, A. J. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000151029.58752.27 · Cited by 98 · see citing works

Evaluation of De-O-Acetylated Meningococcal C Polysaccharide-Tetanus Toxoid Conjugate Vaccine in Infancy: Reactogenicity, Immunogenicity, Immunologic Priming, and Bactericidal Activity against O-Acetylated and De-O-Acetylated Serogroup C Strains

Richmond, P., Borrow, R., Findlow, J., Martin, S. L., Thornton, C., Cartwright, K. A. V., & Miller, E. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2378-2382.2001 · Cited by 93 · see citing works

Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents

Gill, C. J., Baxter, R. P., Anemona, A., Ciavarro, G., & Dull, P. M. (2010) · Human Vaccines · doi:10.4161/hv.6.11.12849 · Cited by 86 · see citing works

Antibody Persistence after Serogroup C Meningococcal Conjugate Immunization of United Kingdom Primary‐School Children in 1999–2000 and Response to a Booster: A Phase 4 Clinical Trial

Perrett, K. P., Winter, A. P., Kibwana, E., Jin, C., John, T. M., Yu, L., Borrow, R., Curtis, N. C., & Pollard, A. J. (2010) · Clinical Infectious Diseases · doi:10.1086/652765 · Cited by 83 · see citing works

Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine

de Voer, R. M., Mollema, L., Schepp, R. M., de Greeff, S. C., van Gageldonk, P. G. M., de Melker, H. E., Sanders, E. A. M., Berbers, G. A. M., & van der Klis, F. R. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012144 · Cited by 80 · see citing works

A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children

Knuf, M., Kieninger‐Baum, D., Habermehl, P., Muttonen, P., Maurer, H., Vink, P., POOLMAN, J. T., & Boutriau, D. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.064 · Cited by 79 · see citing works

Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood

Anttila, M. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00458-7 · Cited by 78 · see citing works

Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-Adjuvanted Prepandemic Candidate Influenza Vaccines in Children Aged 3 to 9 Years

Díez‐Domingo, J., Garcés‐Sánchez, M., Baldó, J.-M., Planelles, M. V., Ubeda, I., Jubert, A., Marés, J., Moris, P., Garcı́a-Corbeira, P., Dramé, M., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181daf921 · Cited by 76 · see citing works

The Impact of Childhood Meningococcal Serogroup C Conjugate Vaccine Programs in Canada

Bettinger, J. A., Scheifele, D. W., Saux, N. L., Halperin, S. A., Vaudry, W., & Tsang, R. S. W. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31819040e7 · Cited by 76 · see citing works

Seroprevalence of Antibodies against Serogroup C Meningococci in England in the Postvaccination Era

Trotter, C. L., Borrow, R., Findlow, J., Holland, A., Frankland, S., Andrews, N. J., & Miller, E. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00279-08 · Cited by 70 · see citing works

Persistence, Replacement, and Rapid Clonal Expansion of Meningococcal Carriage Isolates in a 2008 University Student Cohort

Bidmos, F. A., Neal, K. R., Oldfield, N. J., Turner, D. P. J., Ala’Aldeen, D. A. A., & Bayliss, C. D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01322-10 · Cited by 70 · see citing works

Seroprevalence and Placental Transportation of Maternal Antibodies Specific forNeisseria meningitidisSerogroup C,Haemophilus influenzaeType B, Diphtheria, Tetanus, and Pertussis

de Voer, R. M., van der Klis, F. R. M., Nooitgedagt, J. E., Versteegh, F. G. A., van Huisseling, J. C. M., van Rooijen, D. M., Sanders, E. A. M., & Berbers, G. A. M. (2009) · Clinical Infectious Diseases · doi:10.1086/599347 · Cited by 69 · see citing works

Immunogenicity of a Reduced Schedule of Meningococcal Group C Conjugate Vaccine Given Concomitantly with the Prevenar and Pediacel Vaccines in Healthy Infants in the United Kingdom

Southern, J., Borrow, R., Andrews, N. J., Morris, R., Waight, P., Hudson, M., Balmer, P., Findlow, H., Findlow, J., & Miller, E. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00420-08 · Cited by 68 · see citing works

Revised Recommendations of the Advisory Committee on Immunization Practices to Vaccinate All Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine

(2007) · PsycEXTRA Dataset · doi:10.1037/e669332007-003 · Cited by 66 · see citing works

Impact of the meningococcal C conjugate vaccine in Spain: an epidemiological and microbiological decision

Cano, R., Larrauri, A., Mateo, S., Alcalá, B., Salcedo, C., & Vázquez, J. A. (2004) · Eurosurveillance · doi:10.2807/esm.09.07.00474-en · Cited by 65 · see citing works

Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2–10 years of age

Halperin, S. A., Gupta, A. K., Jeanfreau, R. J., Klein, N. P., Reisinger, K. S., Walter, E. B., Bedell, L., Gill, C. J., & Dull, P. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.092 · Cited by 64 · see citing works

Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP/Hib vaccine

Southern, J., Crowley-Luke, A., Borrow, R., Andrews, N. J., & Miller, E. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.060 · Cited by 56 · see citing works

Decline in Meningococcal Antibody Levels in African Children 5 Years after Vaccination and the Lack of an Effect of Booster Immunization

Ceesay, S. J., Allen, S. J., Menon, A., Todd, J., Cham, K., Carlone, G. M., Turner, S. H., Gheesling, L. L., DeWitt, W. E., Plikaytis, B. D., et al. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1212 · Cited by 55 · see citing works

Immunogenicity and Reactogenicity of Primary Immunization With a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Polio-Haemophilus Influenzae Type B Vaccine Coadministered With Two Doses of a Meningococcal C-Tetanus Toxoid Conjugate Vaccine

Torres, J. C. T., Moro, M., Ruíz-Contreras, J., Castro, J., mez-Campder, J. A. G., Navarro, M. L., Merino, J., n-Ancel, A. M., Roca, J., Garc??a-del-R??o, M., et al. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000227725.61495.c4 · Cited by 54 · see citing works

Effects of Prior Polysaccharide Vaccination on Magnitude, Duration, and Quality of Immune Responses to and Safety Profile of a Meningococcal Serogroup C Tetanus Toxoid Conjugate Vaccination in Adults

Southern, J., Deane, S., Ashton, L., Borrow, R., Goldblatt, D., Andrews, N. J., Balmer, P., Morris, R., Kroll, J. S., & Miller, E. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.6.1100-1104.2004 · Cited by 50 · see citing works

Meningococcal antibody titres in infants of women immunised with meningococcal polysaccharide vaccine during pregnancy.

O’Dempsey, T., MCARDLE, T. F., Ceesay, S. J., Secka, O., Demba, E., BANYA, W. A. S., Francis, N. A., & Greenwood, B. M. (1996) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.74.1.f43 · Cited by 46 · see citing works

A Randomized, Multicenter, Open-Label Clinical Trial to Assess the Immunogenicity of a Meningococcal C Vaccine Booster Dose Administered to Children Aged 14 to 18 Months

Díez‐Domingo, J., Planelles, M. V., Baldó, J. M., Sansano, M. I. U., Jubert, A., Merino, Á. H., de Miguel, Á. G., González, J. B., & Marcos, M. D. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181b9a831 · Cited by 43 · see citing works

Safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine after one or two doses given to infants and toddlers

Halperin, S. A., Díaz‐Mitoma, F., Dull, P. M., Anemona, A., & Ceddia, F. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0848-8 · Cited by 38 · see citing works

Plasma and memory B‐cell kinetics in infants following a primary schedule of CRM197‐conjugated serogroup C meningococcal polysaccharide vaccine

Kelly, D. F., Snape, M. D., Perrett, K. P., Clutterbuck, E., Lewis, S., Rohner, G. B., Jones, M., Yu, L., & Pollard, A. J. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02934.x · Cited by 37 · see citing works

Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease.

(2009) · PubMed · Cited by 37 · see citing works

Modeling Future Changes to the Meningococcal Serogroup C Conjugate (MCC) Vaccine Program in England and Wales

Trotter, C. L., Edmunds, W. J., Ramsay, M. E., & Miller, E. (2006) · Human Vaccines · doi:10.4161/hv.2.2.2611 · Cited by 35 · see citing works

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations

Khatami, A., Snape, M. D., Davis, E., Layton, H., John, T. M., Yu, L., Dull, P. M., Gill, C. J., Odrjlin, T., Dobson, S., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.02.046 · Cited by 35 · see citing works

Immunogenicity of a Single Dose of Meningococcal Group C Conjugate Vaccine Given at 3 Months of Age to Healthy Infants in the United Kingdom

Findlow, H., Borrow, R., Andrews, N. J., Waight, P., Sheasby, E., Matheson, M., England, A., Goldblatt, D., Ashton, L., Findlow, J., et al. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31824f34e6 · Cited by 31 · see citing works

Prevention of meningococcal serogroup C disease by NeisVac-C™

Borrow, R., & Findlow, J. (2009) · Expert Review of Vaccines · doi:10.1586/14760584.8.3.265 · Cited by 28 · see citing works

Immunogenicity and Reactogenicity of a Booster Dose of a Novel Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine Given to Toddlers of 13–14 Months of Age With Antibody Persistence Up to 31 Months of Age

Torres, J. C. T., Moro, M., Merino, J., Gómez-Campderá, J. A., García-del-Rio, M., Jurado, A., Díez-Delgado, F. J., Omeñaca, F., García-Sicilia, J., Ruíz-Contreras, J., et al. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31816b4561 · Cited by 28 · see citing works

Immunogenicity and Safety of a Meningococcal Serogroup A, C, Y and W Glycoconjugate Vaccine, ACWY-TT

Findlow, H., & Borrow, R. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0032-5 · Cited by 24 · see citing works

ANTIBODY PERSISTENCE 12 MONTHS AFTER A BOOSTER DOSE OF MENINGOCOCCAL-C CONJUGATED VACCINE IN THE SECOND YEAR OF LIFE

Díez‐Domingo, J., Planelles, M. V., Baldó, J. M., Úbeda-Sansano, I., Jubert, A., Puig‐Barberà, J., & Gutiérrez-Gimeno, M. V. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181d9e653 · Cited by 20 · see citing works

Immunogenicity of Fractional Doses of Tetravalent A/C/Y/W135 Meningococcal Polysaccharide Vaccine: Results from a Randomized Non-Inferiority Controlled Trial in Uganda

Guerin, P. J., Næss, L. M., Fogg, C., Rosenqvist, E., Pinoges, L., Bajunirwe, F., Nabasumba, C., Borrow, R., Frøholm, L. O., Ghabri, S., et al. (2008) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000342 · Cited by 19 · see citing works

Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine

Kitchin, N. R. E., Southern, J., Morris, R., Borrow, R., Fiquet, A., Boisnard, F., Thomas, S., & Miller, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.049 · Cited by 17 · see citing works

Outbreak of serogroup C meningococcal disease in Veneto region, Italy

Ferro, A. M., Baldo, V., Cinquetti, S., Corziali, P., Gallo, G., Lustro, G., Paludetti, P., Menegon, T., Baldovin, T., Palù, G., et al. (2008) · Eurosurveillance · doi:10.2807/ese.13.02.08008-en · Cited by 14 · see citing works

Persistence of Serum Bactericidal Antibody One Year After a Booster Dose of Either a Glycoconjugate or a Plain Polysaccharide Vaccine Against Serogroup C Neisseria meningitidis Given to Adolescents Previously Immunized With a Glycoconjugate Vaccine

de Whalley, P., Snape, M. D., Kelly, D. F., Banner, C., Lewis, S., Diggle, L., John, T. M., Yu, L., Omar, O., Borkowski, A., et al. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318224fb14 · Cited by 13 · see citing works

Meningococcal vaccines in Canada: An update

Salvadori, M., Bortolussi, R. A., & Canadian Paediatric Society (2011) · Paediatrics & Child Health · doi:10.1093/pch/16.8.485 · Cited by 11 · see citing works

Community cluster of meningococcal disease by Neisseria meningitidis serogroup C in Andalusia, Spain, March to May 2011

Cortés, J. M. M., Butrón, E. T., Fernández, M. G., Herrador, Z., Osakar, S. H., Luque, R. S., Morilla, E. P., & Enríquez, J. G. (2012) · Eurosurveillance · doi:10.2807/ese.17.36.20261-en · Cited by 5 · see citing works

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM197-conjugated serogroup C meningococcal polysaccharide vaccine (vol 127, pg 134, 2009)

Kelly, D. F., Snape, Perrett, K. P., Clutterbuck, E., Lewis, S. C., Rohner, G. B., Jones, M., L-M., Y., & Pollard, A. J. (2011) · Immunology · Cited by 2 · see citing works

A guide to vaccinology: from basic principles to new developments

Pollard, A. J., & Bijker, E. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00479-7 · Cited by 1,593 · see citing works

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

Borrow, R., Alarcón, P., Carlos, J., Caugant, D. A., Christensen, H., Debbag, R., Wals, P. D., Echániz-Avilés, G., Findlow, J., Head, C., et al. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1258308 · Cited by 273 · see citing works

Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage

Lucidarme, J., Hill, D. M. C., Bratcher, H. B., Gray, S. J., du Plessis, M., Tsang, R. S. W., Vázquez, J. A., Taha, M., Ceyhan, M., Efron, A., et al. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.07.007 · Cited by 220 · see citing works

The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004–2014

Whittaker, R., Dias, J. G., Ramliden, M., Ködmön, C., Economopoulou, A., Beer, N., Pastore Celentano, L., Kanitz, E., Richter, L., Mattheus, W., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.03.007 · Cited by 179 · see citing works

Vaccines against Meningococcal Diseases

Pizza, M., Bekkat-Berkani, R., & Rappuoli, R. (2020) · Microorganisms · doi:10.3390/microorganisms8101521 · Cited by 150 · see citing works

Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies

Booy, R., de Gentile, A. S., Nissen, M. D., Whelan, J., & Abitbol, V. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1532248 · Cited by 103 · see citing works

Meningococcal serogroups and surveillance: a systematic review and survey

Peterson, M. E., Li, Y., Bita, A., Moureau, A., Nair, H., Kyaw, M. H., Abad, R., Bailey, F., Garcia, I. D. L. F., Decheva, A., et al. (2018) · Journal of Global Health · doi:10.7189/jogh.09.010409 · Cited by 100 · see citing works

Progress toward the global control of Neisseria meningitidis : 21st century vaccines, current guidelines, and challenges for future vaccine development

Dretler, A. W., Rouphael, N., & Stephens, D. S. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1451810 · Cited by 87 · see citing works

Glycoconjugate vaccines: an update

Vella, M., & Pace, D. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.993375 · Cited by 73 · see citing works

Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment

Marshall, H. S., Chen, G., Clarke, M. F., & Ratcliffe, J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.11.075 · Cited by 69 · see citing works

Clinical experience with the meningococcal B vaccine, Bexsero ® : Prospects for reducing the burden of meningococcal serogroup B disease

Watson, P. S., & Turner, D. P. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.11.057 · Cited by 68 · see citing works

MENINGOCOCCAL DISEASE IN CHILDHOOD: EPIDEMIOLOGY, CLINICAL FEATURES AND PREVENTION

Esposito, S. (2015) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2015.56.3.498 · Cited by 58 · see citing works

Meningococcal serogroup B vaccine: Knowledge and acceptability among parents in Italy

Morrone, T., Napolitano, F., Albano, L., & Giuseppe, G. D. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1313940 · Cited by 51 · see citing works

Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries

Abad, R., Medina, V., Stella, M., Boccadifuoco, G., Comanducci, M., Bambini, S., Muzzi, A., & Vázquez, J. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150721 · Cited by 48 · see citing works

Herd Protection against Meningococcal Disease through Vaccination

Clark, S. A., & Borrow, R. (2020) · Microorganisms · doi:10.3390/microorganisms8111675 · Cited by 45 · see citing works

Impact of meningococcal C conjugate vaccination four years after introduction of routine childhood immunization in Brazil

Andrade, A. L., Minamisava, R., Tomich, L. G. M. D. M., de Lemos, A. P. S., Gorla, M. C., Brandileone, M. C. D. C., Domingues, C. M. S., de Moraes, C., Policena, G. M., Bierrenbach, A. L., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.03.010 · Cited by 44 · see citing works

Epidemiology of invasive meningococcal B disease in Australia, 1999–2015: priority populations for vaccination

Archer, B. N., Chiu, C. K., Jayasinghe, S. H., Richmond, P., McVernon, J., Lahra, M. M., Andrews, R. M., & McIntyre, P. B. (2017) · The Medical Journal of Australia · doi:10.5694/mja16.01340 · Cited by 44 · see citing works

Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in England

Clark, S. A., Campbell, H. J., Ribeiro, S., Bertran, M., Walsh, L., Walker, A., Willerton, L., Lekshmi, A., Bai, X., Lucidarme, J., et al. (2023) · Journal of Infection · doi:10.1016/j.jinf.2023.09.002 · Cited by 43 · see citing works

Persistence of the immune response after MenACWY-CRM vaccination and response to a booster dose, in adolescents, children and infants

Baxter, R. P., Keshavan, P., Welsch, J. A., Han, L., & Smolenov, I. V. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1136040 · Cited by 41 · see citing works

Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017

Nuttens, C., Findlow, J., Balmer, P., Swerdlow, D. L., & Htar, M. T. T. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.3.2002075 · Cited by 40 · see citing works

Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis

Xu, J., Chen, Y., Yue, M., Yu, J., Han, F., Xu, L., & Shao, Z. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2071077 · Cited by 37 · see citing works

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease

Dbaibo, G. S., Khinkarly, R. W., & Hedari, C. (2014) · Infection and Drug Resistance · doi:10.2147/idr.s36243 · Cited by 36 · see citing works

Frequent capsule switching in ‘ultra-virulent’ meningococci – Are we ready for a serogroup B ST-11 complex outbreak?

Lucidarme, J., Lekshmi, A., Parikh, S. R., Bray, J. E., Hill, D. M. C., Bratcher, H. B., Gray, S. J., Carr, A. D., Jolley, K. A., Findlow, J., et al. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.05.015 · Cited by 34 · see citing works

An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine

Keshavan, P., Pellegrini, M., Vadivelu, K., & Nissen, M. D. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1521280 · Cited by 34 · see citing works

Meningococcal disease epidemiology in Brazil (2005–2018) and impact of MenC vaccination

Nunes, A. A., de Abreu, A. D. J. L., Cintra, O. A. L., Cintra, M. A. C. T., Coelho, E. B., & de Barros, E. N. C. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.11.067 · Cited by 33 · see citing works

Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme

Lawrence, G. L., WANG, H., Lahra, M. M., Booy, R., & McIntyre, P. B. (2016) · Epidemiology and Infection · doi:10.1017/s0950268816000704 · Cited by 33 · see citing works

Impact of vaccination on meningococcal epidemiology

Stefanelli, P., & Rezza, G. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1108502 · Cited by 32 · see citing works

Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections

Jones, C. H., Mohamed, N., Rojas, E. A. P., Andrew, L., Hoyos, J. M., Hawkins, J. C., McNeil, L. K., Jiang, Q. L., Mayer, L. W., Wang, X., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01447-15 · Cited by 31 · see citing works

Antibody persistence and booster responses 24–36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial

Martinón‐Torres, F., Martínez, A. C., Simkó, R., Marquez, P. I., Arimany, J.-L., Giménez‐Sánchez, F., Gianzo, J. A. C., Kovacs, E. M. R., Rojo, P., Wang, H., et al. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.12.005 · Cited by 31 · see citing works

Meningococcal serogroup Y emergence in Europe

Bröker, M., Bukovski, S., Culic, D., Jacobsson, S., Koliou, M., Kuusi, M., Simões, M. J., Skoczyńska, A., Toropainen, M., Taha, M., et al. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28206 · Cited by 31 · see citing works

Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial

Pace, D., Khatami, A., McKenna, J., Campbell, D., Attard-Montalto, S., Birks, J., Voysey, M., White, C., Finn, A., Macloed, E., et al. (2015) · BMJ · doi:10.1136/bmj.h1554 · Cited by 28 · see citing works

Subsets of Memory CD4+ T Cell and Bactericidal Antibody Response to Neisseria meningitidis Serogroup C after Immunization of HIV-Infected Children and Adolescents

Milagres, L. G., Costa, P. R., da Silva, G. P., Carvalho, K. I., PEREIRA-MANFRO, W. F., Ferreira, B., Barreto, D. M., Frota, A. C. C., Hofer, C. B., & Kallas, E. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115887 · Cited by 28 · see citing works

UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis

Jackson, C., Yarwood, J., Saliba, V., & Bedford, H. E. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-012851 · Cited by 28 · see citing works

Polysaccharide conjugate vaccine: A kind of vaccine with great development potential

Zhao, J. R., Hu, G., Huang, Y., Huang, Y., Wei, X., & Shi, J. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.10.013 · Cited by 28 · see citing works

Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy

Pezzotti, P., Miglietta, A., Neri, A., Fazio, C., Vacca, P., Voller, F., Rezza, G., & Stefanelli, P. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.06.002 · Cited by 25 · see citing works

Genotypic Analysis of Meningococcal Factor H-Binding Protein from Non-Culture Clinical Specimens

Clark, S. A., Lucidarme, J., Newbold, L. S., & Borrow, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089921 · Cited by 21 · see citing works

Antibody persistence and booster response 68 months after vaccination at 2–10 years of age with one dose of MenACWY-TT conjugate vaccine

Knuf, M., Helm, K., Kolhe, D. A., der Wielen, M. V., & Baine, Y. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.04.064 · Cited by 20 · see citing works

Overview of meningococcal epidemiology and national immunization programs in children and adolescents in 8 Western European countries

Cardoso, G. P., Lagrée-Chastan, M., Caséris, M., Gaudelus, J., Haas, H., Leroy, J., Bakhache, P., Pujol, J.-F., Werner, A., Dommergues, M., et al. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.1000657 · Cited by 18 · see citing works

Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants

Vesikari, T., Borrow, R., Costa, X. J. D., Richard, P., Eymin, C., Boisnard, F., & Lockhart, S. P. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.053 · Cited by 17 · see citing works

Towards Predicting Protective Vaccine Responses in the Very Young

Kollmann, T. R., & Marchant, A. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.05.005 · Cited by 16 · see citing works

Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules

Sadarangani, M., Sell, T., Iro, M. A., Snape, M. D., Voysey, M., Finn, A. H. R., Heath, P. T., Bona, G., Esposito, S., Díez‐Domingo, J., et al. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.161288 · Cited by 16 · see citing works

Respiratory Syncytial Virus and US Pediatric Intensive Care Utilization

Shanklin, A., Olson, T. L., Patel, A. K., Rivera, E. A. T., & Pollack, M. M. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.40997 · Cited by 15 · see citing works

Fast and accurate dynamic estimation of field effectiveness of meningococcal vaccines

Argante, L., Tizzoni, M., & Medini, D. (2016) · BMC Medicine · doi:10.1186/s12916-016-0642-2 · Cited by 14 · see citing works

Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence

Alderfer, J., Srivastava, A. K., Istúriz, R., Burman, C., Absalon, J., Beeslaar, J. F., & Perez, J. L. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1581542 · Cited by 13 · see citing works

Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil

Macêdo, L. E. N., Ferreira, V. M., Feitosa, C. A., Nunes, A. M. P. B., Campos, L. C., & Sáfadi, M. A. P. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1415682 · Cited by 12 · see citing works

Editorial Commentary: Fifteen Years of Protection by Meningococcal C Conjugate Vaccines: Lessons From Disease Surveillance

Maiden, M. C. J., & MacLennan, J. M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu599 · Cited by 12 · see citing works

Meningococcal C conjugate age-dependant long-term loss of effectiveness

Garrido‐Estepa, M., Nunez, O. G., León-Gómez, I., Cano, R., & Herruzo, R. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.044 · Cited by 10 · see citing works

Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing

Jaishwal, P., Jha, K., & Singh, S. P. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134012 · Cited by 10 · see citing works

Impact of meningococcal C conjugate vaccination campaign in Emilia-Romagna, Italy

Pascucci, M. G., Gregori, V. D., Frasca, G., Rucci, P., Finarelli, A. C., Moschella, L., Borrini, B. M., Cavrini, F., Liguori, G., Sambri, V., et al. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27597 · Cited by 10 · see citing works

The Multicomponent Meningococcal Serogroup B Vaccine (4CMenB): Origin, Composition, Health Impact and Unknown Aspects

Mameli, C., Galli, E., Mantegazza, C., Fabiano, V., & Zuccotti, G. (2015) · Future Microbiology · doi:10.2217/fmb.15.91 · Cited by 10 · see citing works

Antibody persistence after serogroup C meningococcal conjugate vaccine in children with sickle cell disease

Souza, A. R., Maruyama, C., Sáfadi, M. A. P., Lopes, M. H., Azevedo, R. S., Findlow, H., Bai, X., Borrow, R., & Weckx, L. Y. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.06.072 · Cited by 10 · see citing works

Oropharyngeal Carriage of Meningococcus in Portugal by Group and Clonal Complex 6 Years After Adolescent Vaccine Campaign

Rodrigues, F. M. P., Morales‐Aza, B. M., Christensen, H., Giles, J., Ferreira, M., Sikora, P., Madanelo, I., Lucidarme, J., Januário, L., & Finn, A. H. R. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000860 · Cited by 9 · see citing works

Vacuna conjugada frente al meningococo C: impacto del programa de vacunación y efectividad a largo plazo en Navarra, 2000-2014

Morales, D., Cenoz, M. G., Moreno‐Galarraga, L., Bernaola, E., Barricarte, A., & Castilla, J. (2016) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2015.11.020 · Cited by 8 · see citing works

Suspected cluster of Neisseria meningitidis W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015

Lawler, J., Lucidarme, J., Parikh, S. R., Smith, L., Campbell, H. J., Borrow, R., Gray, S. J., Foster, K., & Ladhani, S. N. (2019) · Eurosurveillance · doi:10.2807/1560-7917.es.2019.24.23.1900070 · Cited by 8 · see citing works

Invasive Meningococcal Disease due to group C N. meningitidis ST11 (cc11): The Tuscany cluster 2015–2016

Menichetti, F., Fortunato, S., Ricci, A., Salani, F., Ripoli, A., Tascini, C., Fusco, F. M., Mencarini, J., Bartoloni, A., & Pietro, M. D. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.08.050 · Cited by 7 · see citing works

Neisseria meningitidis carriage and risk factors among teenagers in Suizhou city in China

He, F., Yang, H., Li, G. M., Zhu, B., Zhang, Y., Jiang, H., Yuan, M., Jiang, Y., & Lv, J. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820002113 · Cited by 7 · see citing works

cgMLST characterisation of invasive Neisseria meningitidis serogroup C and W strains associated with increasing disease incidence in the Republic of Ireland

Mulhall, R., Bennett, D. E., Bratcher, H. B., Jolley, K. A., Bray, J. E., O’Lorcain, P. P., Cotter, S. M., Maiden, M. C. J., & Cunney, R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216771 · Cited by 7 · see citing works

Will booster doses be required for serogroup B meningococcal vaccine?

McQuaid, F., & Snape, M. D. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.878654 · Cited by 7 · see citing works

Immunological Effects of Dimethyldioctadecylammonium Bromide and Saponin as Adjuvants for Outer Membrane Vesicles from Neisseria meningitidis

Correa, V. A., Portilho, A. I., & Gaspari, E. D. (2022) · Diseases · doi:10.3390/diseases10030046 · Cited by 6 · see citing works

Preparation and Characterization of a Staphylococcus aureus Capsular Polysaccharide-Protein Conjugate Prepared by a Low Cost Technique: a Proof-of-Concept Study

Pujato, N., Díaz, G., Barbagelata, M. S., Vicco, M. H., Calvinho, L. F., & Marcipar, I. S. (2014) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-014-1246-y · Cited by 6 · see citing works

Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines

Jonker, E. F. F., van Ravenhorst, M. B., Berbers, G. A. M., & Visser, L. G. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.05.064 · Cited by 6 · see citing works

Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali

Basta, N. E., Borrow, R., Berthe, A., Traore, A., Onwuchekwa, U., Townsend, K., Boukary, R. M., Mabey, L., Findlow, H., Bai, X., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ602 · Cited by 5 · see citing works

Epidemiology and genetic diversity of invasive Neisseria meningitidis strains circulating in Portugal from 2003 to 2020

Bettencourt, C. R., Nunes, A., Nogueira, P., Duarte, S., Silva, C., Gomes, J. P., & Simões, M. J. (2023) · International Microbiology · doi:10.1007/s10123-023-00463-w · Cited by 5 · see citing works

Vaccine Design in the 21st Century

Bottomley, M. J., Rappuoli, R., & Finco, O. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802174-3.00003-5 · Cited by 5 · see citing works

Attitudes of Swiss Health Care Providers Toward Childhood Immunizations

Schuler, M., Schaedelin, S. A., Aebi, C., Berger, C., Crisinel, P. A., Diana, A., Niederer-Loher, A., Siegrist, C., Vaudaux, B. P., & Heininger, U. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001522 · Cited by 5 · see citing works

Potential impact of the 4CMenB vaccine on oropharyngeal carriage of Neisseria meningitidis

Abad, R., Medina, V., Fariñas, M. C., Martı́nez-Martı́nez, L., Bambini, S., Dari, A., Medini, D., Pizza, M., & Vázquez, J. A. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.09.021 · Cited by 5 · see citing works

Avogadro Limit Washed out by Nano-Associates of Water which Continue as Information Carriers in Serial Dilutions and End up with Generalized Concept of Medicines

Mahata, C. (2017) · International Journal of Complementary & Alternative Medicine · doi:10.15406/ijcam.2017.09.00305 · Cited by 5 · see citing works

Conjugate vaccines dramatically reshaped the epidemiology of bacterial meningitis in a well‐defined child population

Ladomenou, F., Tzanakaki, G., Kolyva, S., Katsarakis, I., Maraki, S., & Galanakis, E. (2019) · Acta Paediatrica · doi:10.1111/apa.14957 · Cited by 5 · see citing works

Evaluating the Impact of Meningococcal Vaccines With Synthetic Controls

Prunas, O., Weinberger, D. M., Medini, D., Tizzoni, M., & Argante, L. (2021) · American Journal of Epidemiology · doi:10.1093/aje/kwab266 · Cited by 4 · see citing works

La enfermedad meningocócica y las vacunas: algunas respuestas y todavía muchas preguntas

Godoy, P., Castilla, J., Astray, J., Tuells, J., Barrabeig, I., & Domı́nguez, Á. (2019) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2019.09.004 · Cited by 4 · see citing works

Surveillance of bacterial meningitis in an Angolan pediatric hospital after the introduction of pneumococcal conjugate vaccines

Urtti, S., Cruzeiro, M. L., de Gouveia, L., Peltola, H., von Gottberg, A., Kyaw, M. H., & Pelkonen, T. (2019) · Journal of Global Health Reports · doi:10.29392/joghr.3.e2019091 · Cited by 4 · see citing works

The difficult road to new vaccines for pertussis and serogroup B meningococcal disease

GORRINGE, A. R. (2015) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.4784 · Cited by 3 · see citing works

Meningococcal serogroup B disease in Turkey

Bakır, M. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28438 · Cited by 3 · see citing works

Seroprevalence of meningococcal serogroup C bactericidal antibodies in the Portuguese population, a decade after vaccine introduction in the National Immunisation Programme

Gonçalves, P., Sáez-López, E., Carneiro, S., & Simões, M. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250103 · Cited by 3 · see citing works

Seroprevalence of meningococcal ACWY antibodies across the population in the Netherlands: Two consecutive surveys in 2016/17 and 2020

Ohm, M., Knol, M. J., Vos, E. R. A., Bogaard, M., van Rooijen, D. M., Sanders, E. A. M., de Melker, H. E., van der Klis, F. R. M., & Berbers, G. A. M. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.11.045 · Cited by 2 · see citing works

Entzündliche Erkrankungen

Warnke, C., Havla, J. B., Kitzrow, M., Biesalski, A., & Knauß, S. (2018) · Springer eBooks · doi:10.1007/978-3-662-56784-5_2 · Cited by 2 · see citing works

Seroprevalence of antibodies against serogroup C meningococci in the region of Valencia, Spain: Impact of meningococcal C conjugate vaccination

Pérez–Breva, L., Abad, R., Martínez‐Beneito, M. A., Puig‐Barberà, J., Alemán-Sánchez, S., Talamante, N. M., Sastre-Cantón, M., Vázquez, J. A., & Díez‐Domingo, J. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.04.022 · Cited by 1 · see citing works

Efetividade da vacina conjugada contra o meningococo C em menores de dois anos

Conde, M. T. R. P. (2014) · doi:10.11606/t.6.2014.tde-03112014-085727 · Cited by 1 · see citing works

Vacunas multivalentes frente a enfermedad meningocócica: ¿dentro o fuera de nuestras agendas?

Abad, R., & Vázquez, J. A. (2014) · Anales de Pediatría · doi:10.1016/j.anpedi.2014.06.015

Immunisation schedule 2017: Practical considerations

Donovan, H. (2017) · Practice Nursing · doi:10.12968/pnur.2017.28.11.486

Evaluation of Mucosal Vaccines against Pneumococcal and Meningococcal Diseases

dos Santos, A. M. P., Pereira, I., Miguez, M., Argondizzo, A., & Rocha‐Leão, M. H. M. (2017) · International Journal of Vaccines & Vaccination · doi:10.15406/ijvv.2017.04.00091

Doença meningocócica no Brasil : descrição de casos, evidência da efetividade e do impacto da vacina anti-meningocócica conjugada sorogrupo C, 2001 – 2013

de Moraes, C. (2016) · doi:10.26512/2016.10.t.22773

Genus Neisseria

Abad, R., & Vázquez, J. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00174-9

Evaluation of Meningococcal Serogroup C Bactericidal Antibodies after Primary Vaccination: A Multicentre Study, Italy

Neri, A., Fabiani, M., Barbui, A. M., Vocale, C., Miglietta, A., Fazio, C., Carannante, A., Palmieri, A., Vacca, P., Ambrosio, L., et al. (2022) · Vaccines · doi:10.3390/vaccines10050778

Imunização parenteral e de mucosas com Vesículas de Membrana Externa de Neisseria meningitidis do sorogrupo C visando reatividade com sorogrupo W em camundongos

Portilho, A. I. (2021) · doi:10.11606/d.87.2021.tde-08122022-115959

NEISSERIA MENINGITIDIS NO RIO GRANDE DO SUL: UMA COMPARAÇÃO DA EFETIVIDADE VACINAL SOBRE OS SOROGRUPOS MAIS PREVALENTES

Lucatelli, J. F., Bartz, F. W., & Pereira, R. S. (2025) · Tempus Actas de Saúde Coletiva · doi:10.18569/tempus.v17i2.3230

Immunogenicity, safety and immunological memory of a Brazilian meningococcal C conjugate vaccine on a phase II clinical trial

Martins, R. D. M., Marques, C., de Noronha, T. G., Engstrom, E. M., Sepúlveda, C. D. S., Camacho, L. A. B., Matos, D. C. D. S., da Silva, A. M. V., Leal, M. D. L. M., Jessouroun, E., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127419

Role of the innate immune response in vascular damage caused by Neisseria meningitidis infection

Rojas, V. M. (2018) · doi:10.70675/aa3bf510zf25ez4d6azb517z474dd4b94494

Meningococcal Outbreaks in Tertiary Education Settings in the United Kingdom: Lessons from the 2026 Kent Cluster for Surveillance, Vaccination Policy, and Institutional Preparedness in Sub-Saharan Africa—A Narrative Review

Mhango, M., Moyo, E., Tungwarara, N., Denhere, K., Chirimbana, M., & Dzinamarira, T. (2026) · Infectious Disease Reports · doi:10.3390/idr18030051

A critical appraisal of the recommendations for the use of meningococcal conjugate vaccines

Sáfadi, M. A. P., Berezin, E. N., & Oselka, G. W. (2012) · Jornal de Pediatria · doi:10.2223/jped.2167 · Cited by 27 · see citing works

Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination

van Ravenhorst, M. B., Marinović, A. B., van der Klis, F. R. M., van Rooijen, D. M., van Maurik, M., Stoof, S. P., Sanders, E. A. M., & Berbers, G. A. M. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.10.049 · Cited by 21 · see citing works

Long-term protection in children with meningococcal C conjugate vaccination: lessons learned

Borrow, R., & Miller, E. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.6.851 · Cited by 58 · see citing works

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

Trotter, C. L., Andrews, N. J., Kaczmarski, E. B., Miller, E., & Ramsay, M. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16725-1 · Cited by 571 · see citing works

Timing of an Adolescent Booster after Single Primary Meningococcal Serogroup C Conjugate Immunization at Young Age; An Intervention Study among Dutch Teenagers

Stoof, S. P., van der Klis, F. R. M., van Rooijen, D. M., Knol, M. J., Sanders, E. A. M., & Berbers, G. A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100651 · Cited by 23 · see citing works